Virginia Fisher

Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response

Meagan Montesion, Karthikeyan Murugesan, Dexter X. Jin et al. · Cancer Discovery · 2020 · 231 citations · Full text

Diurnal Variation of Proliferative Activity in the Human Bone Marrow

Alvin M. Mauer, Virginia Fisher, Ruth Scheib · Blood · 1965 · 128 citations · Full text

Characteristics of Cell Proliferation in Four Patients with Untreated Acute Leukemia

Alvin M. Mauer, Virginia Fisher · Blood · 1966 · 101 citations · Full text

Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy by Tumor Mutational Burden in Metastatic Castration-Resistant Prostate Cancer

Ryon P. Graf, Virginia Fisher, Janick Weberpals et al. · JAMA Network Open · 2022 · 78 citations · Full text

Comparison of the Proliferative Capacity of Acute Leukæmia Cells in Bone Marrow and Blood

Alvin M. Mauer, Virginia Fisher · Nature · 1962 · 64 citations

Inflammation, Acute Leukæmia Cells, Bone Marrow Failure +11